Commentary: something new to consider in the treatment of Helicobacter pylori infection?
Division of Gastroenterology and Hepatology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. c-howden@northwestern.edu
C W
CW
Howden
D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D005260:Female; D016481:Helicobacter Infections / Q000188:drug therapy*; D016480:Helicobacter pylori / Q000187:drug effects*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000008:administration & dosage*; D008297:Male; D054328:Proton Pump Inhibitors / Q000008:administration & dosage*; D019821:Simvastatin / Q000008:administration & dosage*
D000900:Anti-Bacterial Agents; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D054328:Proton Pump Inhibitors; D019821:Simvastatin